Inari Medical Inc (NARI)
50.56
+1.32
(+2.68%)
USD |
NASDAQ |
Nov 15, 16:00
50.60
+0.04
(+0.08%)
After-Hours: 20:00
Inari Medical Research and Development Expense (TTM): 104.11M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 104.11M |
| June 30, 2024 | 96.17M |
| March 31, 2024 | 92.35M |
| December 31, 2023 | 87.53M |
| September 30, 2023 | 85.05M |
| June 30, 2023 | 82.67M |
| March 31, 2023 | 80.15M |
| December 31, 2022 | 74.22M |
| September 30, 2022 | 72.54M |
| June 30, 2022 | 65.93M |
| Date | Value |
|---|---|
| March 31, 2022 | 58.99M |
| December 31, 2021 | 51.02M |
| September 30, 2021 | 38.83M |
| June 30, 2021 | 31.55M |
| March 31, 2021 | 23.54M |
| December 31, 2020 | 18.40M |
| September 30, 2020 | 14.57M |
| June 30, 2020 | 11.08M |
| March 31, 2020 | 9.029M |
| December 31, 2019 | 7.220M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
7.220M
Minimum
Dec 2019
104.11M
Maximum
Sep 2024
55.25M
Average
62.46M
Median
Research and Development Expense (TTM) Benchmarks
| TransMedics Group Inc | 50.26M |
| Cutera Inc | 18.38M |
| Stereotaxis Inc | 9.182M |
| Electromed Inc | 0.656M |
| Myomo Inc | 4.090M |